Predictors of antiretroviral adherence

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 16, Issue 4, 2004, Pages 471-484

  Murphy, D A ^a   Marelich, W D ^b   Huffman, D ^a   Steers, W N ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT;

ABDOMINAL PAIN; ADULT; AGE; ALCOHOL ABUSE; ANXIETY; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOCTOR PATIENT RELATION; DRUG ERUPTION; DRY SKIN; DYSGEUSIA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MENTAL HEALTH; MUSCLE WEAKNESS; NAUSEA; NEPHROLITHIASIS; PARESTHESIA; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SOCIAL SUPPORT; SUBSTANCE ABUSE; VOMITING;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; SOCIAL SUPPORT; SUBSTANCE-RELATED DISORDERS;

EID: 2442585171     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120410001683402     Document Type: Article

References (58)

1. ALTICE, F.L., MOSTASHARI, F. & FRIEDLAND, G.H. (2001). Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 28, 47-58.
2. AMMASSARI, A., MURRI, R., PEZZOTTI, P., TROTTA, M.P., RAVASIO, L., DE LONGIS, P., LO CAPUTO, S., NARCISO, P., PAULUZZI, S., CAROSI, G., NAPPA, S., PIANO, P., Izzo, C.M., LICHTNER, M., REZZA, G., MONFORTE, A., IPPOLITO, G, D'ARMINIO MORONI, M., WU, A.W. & ANTINORI, A. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445-449.
3. BALESTRA, P., FERRI, F., GALGANI, S., NARCISO, P., PELLICELLI, A., TOZZI, V., ZACCARELLI, M. & VISCO, G. (1996). Clinical, psychological, and behavioral characteristics of HIV patients reporting low compliance to treatments. Paper presented at International Conference on AIDS, Vancouver, Canada, July 1996.
4. BERKMAN, L. & SYME, S.L. (1979). Social networks, host resistance and mortality: a nine-year follow-up study of Alameda County residents. American Journal of Epidemiology, 109, 186-204.
5. BLOOM, J.R. (1990). The relationship of social support and health. Social Science and Medicine, 30, 635-637.
6. BROERS, B., MORABIA, A. & HIRSCHEL, B. (1994). A cohort study of drug users' compliance with zidovudine treatment. Archives of Internal Medicine, 154, 1121-1127.
7. CATZ, S.L., KELLY, J.A., BOGART, L.M., BENOTSCH, E.G. & MCAULIFFE, T.L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
8. CHESNEY, M.A. & FOLKMAN, S. (1994). Psychological impact of HIV disease and implications for intervention. Psychiatric Clinics of North America, 17, 163-182.
9. CHESNEY, M.A., FOLKMAN, S. & CHAMBERS, D. (1996). Coping effectiveness training for men living with HIV: preliminary findings. International Journal of STD and AIDS, 7 (Suppl. 2), 75-83.
10. CHESNEY, M.A., ICKOVICS, J.R., CHAMBERS, D.B., GIFFORD, A.L., NEIDIG, J., ZWICKL, B. & WU, A.W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255-266.
11. COCKRAM, A., JUDD, F.K., MIJCH, A. & NORMAN, T. (1999). The evaluation of depression in inpatients with HIV disease. Australian and New Zealand Journal of Psychiatry, 33, 344-352.
12. COOK, R.L., SEREIKA, S.M., HUNT, S.C., WOODWARD, W.C., ERLEN, J.A. & CONIGLIARO, J. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine, 16, 83-88.
13. CUTRONA, C.E. (1989). Ratings of social support by adolescents and adult informants: degree of correspondence and prediction of depressive symptoms. Journal of Personality and Social Psychology, 57, 723-730.
14. CUTRONA, C.E. & RUSSELL, D.W. (1987). The provisions of social relationships and adaptation to stress. In: JONES, W.H. & PERLMAN, D. (Eds), Advances in personal relationships (pp. 37-67). Greenwich, CT: JAI Press.
15. DUNKEL-SCHETTER, C. (1984). Social support and cancer: findings based on patient interviews and their implications. Journal of Social Issues, 40, 77-98.
16. ELDRED, L. (1997). Adherence in the era of protease inhibitors (The Hopkins HIV Report, July 1997). Baltimore: The John Hopkins University AIDS Service. [On-line] http://hopkins-aids.edu/.
17. FRIEDLAND, G.H. (1997). Adherence: the Achilles' heel of highly active antiretroviral therapy. In: Improving the management of HIV disease (pp. 13-15). International AIDS Society-USA.
18. GALASSI, J.P, SCHANBERG, R. & WARE, W.B. (1992). The Patient Reactions Assessment: a brief measure of the quality of the patient-provider medical relationship. Psychological Assessment, 4, 346-351.
19. GORDILLO, V., DEL AMO, J., SORIANO, V. & GONZALEZ-LAHOZ, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
20. GOVE, W.R., STYLE, C.B. & HUGHES, M. (1990). The effect of marriage on the wellbeing of adults. Journal of Family Issues, 11, 4-35.
21. HARRISON, K., VLAHOV, D., JONES, K., CHARRON, K. & CLEMENTS, M.L. (1995). Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. Journal of AIDS and Human Retrovirology, 10, 386-390.
22. HAUBRICH, R.H., LITTLE, S.J., CURRIER, J.S., FORTHAL, D.N., KEMPER, C.A., BEALL, G.N., JOHNSON, D., DUBE, M.P., HWANG, J.Y. & MCCUTCHAN, J.A. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13, 1099-1107.
23. Ho, D.D., NEUMAN, A.U., PERELSON, A.S., CHEN, W., LEONARD, J.M. & MARKOWITZ, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373, 123-126.
24. HOSMER, D.W. & LEMESHOW, S. (2000). Applied logistic regression (2nd edn). New York: Wiley.
25. HOUSE, J., ROBBINS, C. & METZNER, H. (1982). The association of social relationships and activities with mortality: perspective evidence from the Techumseh community health study. American Journal of Epidemiology, 116, 123-140.
26. IMREY, P.B. (2000). Poisson regression, logistic regression, and loglinear models for random counts. In: TINSLEY, H.E.A. & BROWN, S.D. (Eds), Handbook of applied multivariate statistics and mathematical modeling (pp. 391-449). San Diego, CA: Academic Press.
27. KELLY, J.A., MURPHY, D.A., BAHR, G.R, KALICHMAN, S.C., MORGAN, M.G., STEVENSON, L.Y., KOOB, J.J., BRASFIELD, T.L. & BERNSTEIN, B.M. (1993a). Outcomes of cognitive-behavioral and support group brief therapies for depressed persons diagnosed with HIV infection. American Journal of Psychiatry, 150, 1679-1686.
28. KELLY, J.A., MURPHY, D.A., BAHR, G.R, KOOB, J.J., MORGAN, M.G., KALICHMAN, S.C., STEVENSON, L.Y., BRASFIELD, T.L., BERNSTEIN, B.M. & ST. LAWRENCE, J.S. (1993b). Factors associated with severity of depression among persons diagnosed with human immunodeficiency virus (HIV) infection. Health Psychology, 12, 215-219.
29. KLEEBERGER, C.A., PHAIR, J.P., STRATHDEE, S.A., DETELS, R., KINGSLEY, L. & JACOBSON, L.P. (2001). Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. Journal of AIDS, 26, 82-92.
30. LUBIN, B. (1967). Manual for the depression adjective checklist. San Diego, CA: Educational and Industrial Testing Services.
31. LUCAS, G.M., GEBO, K.A., CHAISSON, R.E. & MOORE, R.D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16, 767-774.
32. LYKETSOS, C.G., HOOVER, D.R., GUCCIONE, M., DEW, M.A., WESCH, J.E., BING, E.G. & TREISMAN, G.J. (1996). Changes in depressive symptoms as AIDS develops. American Journal of Psychiatry, 153, 1430-1437.
33. MARELICH, W.D. & MURPHY, D.A. (2003). Effects of empowerment among HIV-positive women on the patient-provider relationship. AIDS Care, 15, 475-481.
34. MARELICH, W.D., ROBERTS, K.J., MURPHY, D.A. & CALLARI, T. (2002). HIV/AIDS patient involvement in antiretroviral treatment decisions. AIDS Care, 14, 17-26.
35. MARTIN, J.E. & DUBBERT, P.M. (1986). Exercise and health: the adherence problem. Behavioral Medicine Update, 4, 16-24.
36. MOATTI, J.P., CARRIERI, M.P., SPIRE, B., GASTAUT, J.A., CASSUTO, J.P & MOREAU, J. (2000). Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS, 14, 151-155.
37. MONTANER, J.S.G., REISS, P., COOPER, D., VELLA, S., HARRIS, M., CONWAY, B., WAINBERG, M.A., SMITH, D., ROBINSON, P., HALL, D., MYERS, M. & LANGE, J.M.A. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS trial. Journal of the American Medical Association, 279, 930-937.
38. MURPHY, D.A., GREENWELL, L. & HOFFMAN, D. (2002). Factors associated with antiretroviral adherence among HIV-infected women with children. Women & Health, 36, 97-111.
39. MURPHY, D.A., MOSCICKI, A.B., VERMUND, S.H. & MUENZ, L.R. (2000b). Psychological distress among HIV-positive adolescents in the REACH Study: effects of life stress, social support, and coping. Journal of Adolescent Health, 27, 391-398.
40. MURPHY, D.A., ROBERTS, K.J., HOFFMAN, D., MOLINA, A. & LU, M.C. (2003). Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care, 15, 217-230.
41. MURPHY, D.A., ROBERTS, K.J., MARTIN, D.J., MARELICH, W. & HOFFMAN, D. (2000a). Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care and STDs, 14, 47-58.
42. MURPHY, D.A., WILSON, C.M., DURAKO, S.J., MUENZ, L.R & BELZER, M. (2001). Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort. AIDS Care, 13, 27-40.
43. PATERSON, D., SWINDELLS, S., MOHR, J., BRESTER, M., VERGIS, E., SQUIER, C., WAGENER, M. & SINGH, N. (1999). How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMS Caps. Presented at the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, IL.
44. PATERSON, D.L., SWINDELLS, S., MOHR, J., BRESTER, M, VERGIS, E.N., SQUIER, C., WAGENER, M.M. & SINGH, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
45. PERELSON, A.S., NEUMAN, A.U., MARKOWITZ, M., LEONARD, J.M. & HO, D.D. (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science, 271, 1582-1586.
46. RADLOFF, L.S. (1977). The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
47. REES, D.W. (1985). Health beliefs and compliance with alcoholism treatment. Journal of Studies on Alcohol, 46, 517-524.
48. REVICKI, D.A., CHAN, K. & GEVIRTZ, F. (1998). Discriminant validity of the medical outcomes study cognitive function scale in HIV disease patients. Quality of Life Research, 7, 551-559.
49. ROBERTS, R.E., ANDREWS, J.A., LEWINSOHN, P.M. & HOPS, H. (1990). Assessment of depression in adolescents using the center for epidemiologic studies depression scale. Psychological Assessment, 2, 122-128.
50. ROBERTS, R.E., LEWINSOHN, P.M. & SEELEY, J.R. (1991). Screening for adolescent depression: a comparison of depression scales. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 58-66.
51. SAFREN, S.A., OTTO, M.W., WORTH, J.L., SALOMON, E., JOHNSON, W., MAYER, K. & BOSWELL, S. (2001). Two strategies to increase adherence to antiretroviral medication: life-steps and medication monitoring. Behaviour Research & Therapy, 39, 1151-1162.
52. SAMUELS, J.E., HENDRIX, J., HILTON, M., MARANTZ, P.R., SLOAN, V. & SMALL, C.B. (1990). Zidovudine therapy in an inner city population. Journal of Acquired Immune Deficiency Syndromes, 3, 877-883.
53. SIMONI, J.M., FRICK, P.A., LOCKHART, D. & LIEBOVITZ, D. (2002). Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patient Care and STDS, 16, 431-439.
54. SINGH, N., SQUIER, C., SIVEK, C., WAGENER, M., NGUYEN, M.H. & YU, V.L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
55. STEWART, A.L., WARE, J.E. JR., SHERBOURNE, C.D & WELLS, K.B. (1992). Psychological distress/wellbeing and cognitive functioning measures. In: STEWART, A.L. & WARE, J.E. JR. (Eds), Measuring functioning and wellbeing: the Medical Outcomes Study approach (pp. 102-142). Durham, NC: Duke University Press.
56. STONE, V.E., HOGAN, J.W., SCHUMAN, P., ROMPALO, A.M, HOWARD, A.A., KORKONTZELOU, C. & SMITH., D.K. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the HER study. Journal of AIDS, 28, 124-131.
57. THOITS, P.A. (1995). Stress, coping, and social support processes: Where are we? What next? Journal of Health and Social Behavior, 35 (Extra Issue: Forty Years of Medical Sociology: The State of the Art and Directions for the Future), 53-79.
58. WARE, J.E., DAVIES-AVERY, A. & BROOK, R.H. (1980). Conceptualization and measurement of health for adults in the Health Insurance Study, Volume VI: Analysis of relationships among health status measures. Santa Monica, CA: RAND Corporation.